NCT00071201View on ClinicalTrials.gov

Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B

PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Chronic Hepatitis B
Interventions
DRUG

Adefovir Dipivoxil for oral suspension, 2 mg/mL

Trial Locations (1)

94404

Gilead Sciences, Inc. 333 Lakeside Drive, Foster City

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY